Author

Kenneth O. Story

Observed names: K O Story, K. Story, Kenneth Story

Observed institutions: Boston University, Northwestern University, University of North Carolina at Chapel Hill, Boston Medical Center, Abbott Northwestern Hospital, Duke University, University of Florida, Northwestern Memorial Hospital, Scripps Green Hospital, University Hospitals Cleveland Medical Center, Mayo Clinic in Arizona, Minneapolis Heart Institute Foundation, University of Pittsburgh Medical Center, Duke Clinical Research Institute, Case Western Reserve University, Baxter (United States)

OpenAlex ID: A5110227937

Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina

2011 · Douglas W. Losordo, Timothy D. Henry, et al. · Circulation Research · 482

Perceived knowledge among patients cared for by nephrologists about chronic kidney disease and end-stage renal disease therapies

2008 · Fredric O. Finkelstein, Kenneth Story, et al. · Kidney International · 268

PDF

Peritoneal dialysis in the US: Evaluation of outcomes in contemporary cohorts

2006 · S. Mujais, K. Story · Kidney International · 223

A Randomized, Controlled Pilot Study of Autologous CD34+ Cell Therapy for Critical Limb Ischemia

2012 · Douglas W. Losordo, Melina R. Kibbe, et al. · Circulation Cardiovascular Interventions · 194

PDF

2008 · Fredric O. Finkelstein, Kenneth Story, et al. · Clinical Journal of the American Society of Nephrology · 165

Effect of Silver Oxide/Trichloroisocyanuric Acid Antimicrobial Urinary Drainage System on Catheter-Associated Bacteriuria

1988 · Anthony J. Schaeffer, Kenneth O. Story, et al. · The Journal of Urology · 117

A prospective evaluation of renal replacement therapy modality eligibility

2008 · D. C. Mendelssohn, S. K. Mujais, et al. · Nephrology Dialysis Transplantation · 110

A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: Design of the RENEW study

2013 · Thomas J. Povsic, Candice Junge, et al. · American Heart Journal · 86

Neighborhood Location, Rurality, Geography, and Outcomes of Peritoneal Dialysis Patients in the United States

2011 · Rajnish Mehrotra, Kenneth Story, et al. · Peritoneal Dialysis International · 58

A Multinational Clinical Validation Study of Pd Adequest 2.0

1999 · for The PD ADEQUEST International Study Group, Edward F. Vonesh, et al. · Peritoneal Dialysis International · 57

Patient and technique survival on peritoneal dialysis in patients with failed renal allograft: A case–control study

2006 · S. Mujais, K. Story · Kidney International · 51

Elevation of whole-blood glutathione in peritoneal dialysis patients by L-2-oxothiazolidine-4-carboxylate, a cysteine prodrug (Procysteine).

1998 · J B Moberly, J Logan, et al. · Journal of the American Society of Nephrology · 34

Determinants of phosphorus mobilization during hemodialysis

2013 · John K. Leypoldt, Baris U. Agar, et al. · Kidney International · 26

Modeling of Icodextrin in PD Adequest® 2.0

2006 · Edward F. Vonesh, Kenneth O. Story, et al. · Peritoneal Dialysis International · 23

Incidence and clinical significance of cardiac biomarker elevation during stem cell mobilization, apheresis, and intramyocardial delivery: An analysis from ACT34-CMI

2012 · Thomas J. Povsic, Douglas W. Losordo, et al. · American Heart Journal · 15

Peritoneal dialysis technique success during the initial 90 days of therapy.

2012 · Steven Guest, Andrew C Hayes, et al. · PubMed · 4

Stability of Procainamide Hydrochloride in Neutralized 5% Dextrose Injection

1988 · Glynn G. Raymond, Michael T. Reed, et al. · American Journal of Health-System Pharmacy · 4

Phase 2 Study of Intramyocardial Injection of Autologous CD34+ Cells to Treat Subjects with Refractory Chronic Myocardial Ischemia (CMI): Factors Influencing Mobilization and Apheresis.

2009 · Deborah Livingston, Delara Motlagh, et al. · Blood · 3

Inline fluid dynamics in piggyback and manifold drug delivery systems

1989 · Nancy C. Leissing, Kenneth O. Story, et al. · American Journal of Health-System Pharmacy · 3

Determination of l-2-oxothiazolidine-4-carboxylic acid (Procysteine®) in human plasma by high-performance liquid chromatography

1994 · Lawrence E. Webb, Mitchell Gechman, et al. · Journal of Chromatography B Biomedical Sciences and Applications · 2

Impact of Mobilization Ability on Cell Functionality and Comparison of Normal and Cmi Subject Samples: an Analysis From Act34–cmi

2013 · Douglas Losordo, Delara Motlagh, et al. · Journal of the American College of Cardiology · 1

PDF

Abstract 11770: Cardiac Biomarker Elevation during Stem Cell Mobilisation, Apheresis and Intramyocardial Delivery is Common but does not Impact Incidence of Long-Term MACE: An Analysis from ACT34-CMI

2012 · Thomas J. Povsic, Douglas W. Losordo, et al. · Circulation · 1

Abstract 12015: Clinical Parameters Influencing Cell Mobilization and Impact of Mobilization Ability on Efficacy Outcomes: An Analysis from ACT34-CMI

2012 · Candice Junge, Delara Motlagh, et al. · Circulation

Works count: 23

Citation count: 1,927

H-index: 15

I10-index: 15